Dr. Piaggio is the Head of the Translational Immunotherapy at the INSERM Immunity and Cancer unit, Institute Curie.
Her research is focused on developing personalized immunotherapies and identifying biomarkers in order to eventually be able to determine which patients will benefit from which immunotherapy. Another area of her research concerns the role of radiotherapy in the activation of the immune system in a pediatric tumor model called rhabdoid tumor (TR). The combination of radiotherapy and immunotherapies could improve the treatment of these aggressive tumors.
By characterizing the transcriptome of each immune cell tumors and ganglia draining tumors Dr. Piaggio and her team will be able to establish how the tumor influences immune cells to create the immunosuppression characteristic of cancer patients.